Educated Patient Lung Cancer Summit On-Demand: Dec. 12, 2020

Adding Zyprexa to ondansetron cut nausea and vomiting safely in abdominal/pelvic radiation with low-emetogenic capecitabine.

February brought in multiple FDA approvals in the oncology space. Here’s an overview of some of the most recent ones.

Patients with oligometastatic lung cancer may live longer with surgery, but experts stress the need for multidisciplinary evaluation to guide treatment choices.

Last week, we saw a few moving parts in the regulatory space, from new NCCN guidelines for pediatric neuroblastoma treatment to FDA Fast Tracks and Priority Reviews

Here is a recap of every FDA approval announced by the regulatory agency in the month of May, spanning various cancer types.

Columvi plus chemo had enhanced survival outcomes vs Rituxan plus chemo in patients with relapsed/refractory diffuse large B-cell lymphoma.